Soros Fund Likes Biogen Idec, Pfizer, Sanofi-Aventis in Q3

Wall St. Watchdog reveals information regarding Soros Fund Management’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 57 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $179.186 million.

  • Davita Inc. (NYSE:DVA): On 06/30/2011 reported holding 504,200 shares with a market value of $43,668,762. This comprised 1.17% of the total portfolio. On 09/30/2011 reported holding 488,000 shares with a market value of $30,582,959. This comprised 1.47% of the total portfolio. The net change in shares for this position over the two quarters is -16,200. About Company: DaVita, Inc. provides dialysis services in the United States for patients suffering from chronic kidney failure. The Company treats patients through a network of owned and managed dialysis facilities in the continental United States.
  • Medicines Co. (NASDAQ:MDCO): On 06/30/2011 reported holding 0 shares. On 09/30/2011 reported holding 1,700,000 shares with a market value of $25,296,000. This comprised 1.21% of the total portfolio. The net change in shares for this position over the two quarters is 1,700,000. About Company: The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.
  • Biogen Idec Inc. (NASDAQ:BIIB): On 06/30/2011 reported holding 0 shares. On 09/30/2011 reported holding 201,000 shares with a market value of $18,723,150. This comprised 0.9% of the total portfolio. The net change in shares for this position over the two quarters is 201,000. About Company: Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company’s products addresses diseases such as multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, crohn’s disease, and psoriasis.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011 reported holding 569,300 shares with a market value of $11,727,580. This comprised 0.31% of the total portfolio. On 09/30/2011 reported holding 666,700 shares with a market value of $11,787,256. This comprised 0.56% of the total portfolio. The net change in shares for this position over the two quarters is 97,400. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Heartware International Inc. (NASDAQ:HTWR): On 06/30/2011 reported holding 15,000 shares with a market value of $1,111,200. This comprised 0.03% of the total portfolio. On 09/30/2011 reported holding 150,000 shares with a market value of $9,661,501. This comprised 0.46% of the total portfolio. The net change in shares for this position over the two quarters is 135,000. About Company: HeartWare International Inc is developing a range of implantable mechanical circulatory assist devices or heart pumps, used for the treatment of congestive heart failure.
  • Baxter International Inc. (NYSE:BAX): On 06/30/2011 reported holding 57,400 shares with a market value of $3,426,206. This comprised 0.09% of the total portfolio. On 09/30/2011 reported holding 117,700 shares with a market value of $6,607,678. This comprised 0.32% of the total portfolio. The net change in shares for this position over the two quarters is 60,300. About Company: Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and research laboratories.
  • Sanofi-aventis (NYSE:SNY): On 06/30/2011 reported holding 0 shares. On 09/30/2011 reported holding 201,400 shares with a market value of $6,605,920. This comprised 0.32% of the total portfolio. The net change in shares for this position over the two quarters is 201,400. About Company: Sanofi-Aventis is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
  • Pharmasset Inc. (NASDAQ:VRUS): On 06/30/2011 reported holding 81,700 shares with a market value of $9,166,740. This comprised 0.25% of the total portfolio. On 09/30/2011 reported holding 75,000 shares with a market value of $6,177,750. This comprised 0.3% of the total portfolio. The net change in shares for this position over the two quarters is -6,700. About Company: Pharmasset, Inc. is a pharmaceutical company. The Company develops oral therapeutics for the human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV).
  • Biomarin Pharmaceutical Inc. (NASDAQ:BMRN): On 06/30/2011 reported holding 191,510 shares with a market value of $5,210,987. This comprised 0.14% of the total portfolio. On 09/30/2011 reported holding 175,000 shares with a market value of $5,577,250. This comprised 0.27% of the total portfolio. The net change in shares for this position over the two quarters is -16,510. About Company: BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin’s subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.
  • Humana Inc. (NYSE:HUM): On 06/30/2011 reported holding 100,200 shares with a market value of $8,070,108. This comprised 0.22% of the total portfolio. On 09/30/2011 reported holding 76,600 shares with a market value of $5,571,118. This comprised 0.27% of the total portfolio. The net change in shares for this position over the two quarters is -23,600. About Company: Humana Inc. is a managed health care company with medical members located in the United States and Puerto Rico. The Company offers coordinated health care through health maintenance organizations, preferred provider organizations, point-of-service plans, and administrative services products. Humana offers its products to employer groups, government-sponsored plans, and individuals.

(Note: Data regarding Soros Fund Management’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet